ConductScience.org, home

Trial · NCT03330236

EEG - Guided Anesthetic Care and Postoperative Delirium

NCT03330236, Not applicable, Completed, Yale University; results first posted 2020-11-09

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. EEG - Guided Anesthetic Care and Postoperative Delirium. Trials, record NCT03330236. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03330236

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
EEG - Guided Anesthetic Care and Postoperative Delirium
NCT number
NCT03330236
Status
Completed
Phases
Not applicable
Enrollment
1,560 participants, actual
Lead sponsor
Yale University
Conditions
Delirium, Emergence Delirium, Anesthesia, General, Electroencephalography, Laparoscopy, Surgical Procedures, Operative
Interventions
Anesthetic "depth" management
First posted
2017-11-06
Last updated
2020-11-09
Results first posted
2020-11-09

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of Participants With Postoperative Deliriumup to five (5) days after surgery
The Number of Participants with Postoperative Delirium is operationally defined as the count of patients with postoperative delirium. Postoperative delirium is an acute brain dysfunction characterized by inattention, disorganized thinking, and a fluctuating course.
SecondaryEmergence Delirium30 min following the extubationIncidence (count) of emergence delirium at post-anesthesia care unit (PACU)
SecondaryNon-delirium Complicationswithin 30 days after surgery
Complications after surgery such as acute kidney injury, cardiac events, cerebrovascular events, renal injury, GI complications, infections (etc) were assessed using the Clavien-Dindo classification. Reported are the count of those with a composite complication Clavien-Dindo Grade ≥II. The classifications are as follows: Grade I = Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Grade II = Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusionsand total parenteral nutritionare also included. Grade III = Requiring surgical, endoscopic or radiological intervention; IIIa = Intervention not under general anesthesia; IIIb = Intervention under general anesthesia. Grade IV = Life-threatening complication (including CNS complications)\* requiring IC/ICU-management; IVa = single organ dysfunction (including dialysis); IVb
SecondaryGI Functional Recoverywithin 30 days after surgerySpeed of GI functional recovery (pass gas)
SecondaryAll-cause 30-day Mortality30 days after surgeryAll-cause 30-day mortality
SecondaryLength of Hospital Stayup to 30 days after surgeryLength of hospital stay was counted from the day of surgery (day 0) to the day when the patient was ready for discharge.
SecondaryICU Admissionup to 72 hoursCount of patients that were admitted to ICU after surgery.
SecondaryLength of ICU Stayup to 30 days after surgerythe duration of time when the patient residing in ICU
OtherNRS Pain Score24 hours after surgeryNumeric Rating Scale subjective pain where 0 indicates no pain and 10 indicates the worst pain.
OtherNRS Sleep Score24 hours after surgeryNumeric Rating Scale subjective sleep quality at 8:00 am where 0 indicates best possible sleep and 10 indicates worst possible sleep

Outcomes10

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYNumber of Participants With Postoperative Deliriumup to five (5) days after surgeryModified ITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYEmergence Delirium30 min following the extubationModified ITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYNon-delirium Complicationswithin 30 days after surgeryModified ITT population/patients with valid data.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYGI Functional Recoverywithin 30 days after surgeryThese data were not collected and analyzed.
SECONDARYAll-cause 30-day Mortality30 days after surgeryModified ITT population/patients with complete dataParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYLength of Hospital Stayup to 30 days after surgeryModified ITT populationdaysMEDIAN
SECONDARYICU Admissionup to 72 hoursModified ITT populationParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYLength of ICU Stayup to 30 days after surgeryThese data were not collected and analyzed.
OTHER_PRE_SPECIFIEDNRS Pain Score24 hours after surgeryThese data were not collected and analyzed.
OTHER_PRE_SPECIFIEDNRS Sleep Score24 hours after surgeryThese data were not collected and analyzed.

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Postoperative DeliriumEEG Guided8Participants
Number of Participants With Postoperative DeliriumUsual Care9Participants
Emergence DeliriumEEG Guided91Participants
Emergence DeliriumUsual Care102Participants
Non-delirium ComplicationsEEG Guided175Participants
Non-delirium ComplicationsUsual Care193Participants
All-cause 30-day MortalityEEG Guided2Participants
All-cause 30-day MortalityUsual Care1Participants
Length of Hospital StayEEG Guided6Inter-Quartile Range 3 to 8days
Length of Hospital StayUsual Care6Inter-Quartile Range 3 to 8days

Participant flow10

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDEEG Guided779
Overall StudySTARTEDUsual Care781
Overall StudyReceived SurgeryEEG Guided779
Overall StudyReceived SurgeryUsual Care781
Overall StudyModified ITTEEG Guided773
Overall StudyModified ITTUsual Care774
Overall StudyCOMPLETEDEEG Guided679
Overall StudyCOMPLETEDUsual Care697
Overall StudyNOT COMPLETEDEEG Guided100
Overall StudyNOT COMPLETEDUsual Care84

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherIntraoperative awarenessGeneral disordersEEG Guided37793
otherIntraoperative awarenessGeneral disordersUsual Care37813

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityEEG Guided2779
Total, all-cause mortalityUsual Care1781
Total, other adverse eventsEEG Guided3779
Total, other adverse eventsUsual Care3781
Total, serious adverse eventsEEG Guided0779
Total, serious adverse eventsUsual Care0781

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons7

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
EEG Guided vs Usual Care: All-cause 30-day MortalityTrial comparisons
EEG Guided vs Usual Care: ICU AdmissionTrial comparisons
EEG Guided vs Usual Care: Non-delirium ComplicationsTrial comparisons
EEG Guided vs Usual Care: Number of Participants With Postoperative DeliriumTrial comparisons
EEG Guided vs Usual Care: deaths from any causeTrial comparisons
EEG Guided vs Usual Care: Emergence DeliriumTrial comparisons
EEG Guided vs Usual Care: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03330236

GET https://conductscience.org/api/trials/v1/NCT03330236/registered